Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Serum 25-hydroxyvitamin D and cancer-related fatigue: associations and effects on depression, anxiety, functional capacity and health-related quality of Life in breast cancer survivors during adjuvant endocrine therapy

Fig. 1

Distribution of breast cancer survivors in the FACIT-Fatigue clusters throughout the study (n = 38). Clusters developed from the 5% MCID between T0T1, T1T2, T0T2 and T0T1T2: The same, Patients who maintained the FACIT-Fatigue score between T0T1, T1T2, T0T2 or who maintained the score at all three times (T0T1T2); Better, Patients who improved the FACIT-Fatigue score between T0T1, T1T2, T0T2 or who improved at T1 and again at T2 (T0T1T2); Worse, Patients who worsened the FACIT-Fatigue score between T0T1, T1T2, T0T2 or who worsened at T1 and again at T2 (T0T1T2); V, Patients who worsened the FACIT-Fatigue score at T1 and improved at T2 (T0T1T2); Inverted V, Patients who improved the FACIT-Fatigue score at T1 and worsened at T2 (T0T1T2). Chi-square Independence Test showed that there was no association between time points of study and clusters, considering T0T1 and T1T2 [X2(2) = 4.452; p = 0.108]

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us